These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 11504806)

  • 21. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively.
    Newman ME; Gur E; Dremencov E; Garcia F; Lerer B; Van de Kar LD
    Neuropharmacology; 2000 Sep; 39(12):2309-17. PubMed ID: 10974314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus.
    Gur E; Dremencov E; Van De Kar LD; Lerer B; Newman ME
    Eur J Pharmacol; 2002 Feb; 436(1-2):57-65. PubMed ID: 11834247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies.
    Gur E; Dremencov E; Lerer B; Newman ME
    Eur J Pharmacol; 2001 Jan; 411(1-2):115-122. PubMed ID: 11137865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
    Watson J; Roberts C; Scott C; Kendall I; Collin L; Day NC; Harries MH; Soffin E; Davies CH; Randall AD; Heightman T; Gaster L; Wyman P; Parker C; Price GW; Middlemiss DN
    Br J Pharmacol; 2001 Jul; 133(6):797-806. PubMed ID: 11454652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The differential effects of food restriction on 5-HT1A and 5-HT1B receptor mediated control of serotonergic transmission in the hippocampus and hypothalamus of rats.
    Gur E; Newman ME; Avraham Y; Dremencov E; Berry EM
    Nutr Neurosci; 2003 Jun; 6(3):169-75. PubMed ID: 12793521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice.
    Evrard A; Laporte AM; Chastanet M; Hen R; Hamon M; Adrien J
    Eur J Neurosci; 1999 Nov; 11(11):3823-31. PubMed ID: 10583471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice.
    Bortolozzi A; Amargós-Bosch M; Toth M; Artigas F; Adell A
    J Neurochem; 2004 Mar; 88(6):1373-9. PubMed ID: 15009637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple 5-HT(1) autoreceptor subtypes govern serotonin release in dorsal and median raphé nuclei.
    Hopwood SE; Stamford JA
    Neuropharmacology; 2001 Mar; 40(4):508-19. PubMed ID: 11249960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors.
    Harrison AA; Markou A
    J Pharmacol Exp Ther; 2001 Apr; 297(1):316-25. PubMed ID: 11259559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.
    Mayorga AJ; Dalvi A; Page ME; Zimov-Levinson S; Hen R; Lucki I
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1101-7. PubMed ID: 11504807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT(1B) receptor knock-out mice.
    Malagié I; David DJ; Jolliet P; Hen R; Bourin M; Gardier AM
    Eur J Pharmacol; 2002 May; 443(1-3):99-104. PubMed ID: 12044798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
    Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
    J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
    Serres F; Muma NA; Raap DK; Garcia F; Battaglia G; Van de Kar LD
    J Pharmacol Exp Ther; 2000 Jul; 294(1):296-301. PubMed ID: 10871325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation.
    Kannari K; Yamato H; Shen H; Tomiyama M; Suda T; Matsunaga M
    J Neurochem; 2001 Mar; 76(5):1346-53. PubMed ID: 11238719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
    Barton CL; Hutson PH
    Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.